Get 250+ investors tailored to your startup

Invest in your industry and stage
Emails & contact info included
Excel and CSV export
Automatically

Trusted by 3,000+ startups

Top 50 Biotech Startup Investors in France in January 2026

Last updated: Jan 2026 A list of 50 angel investors and VC (Venture Capital) funds that invest in Biotech startups based in France. We rank investors based on the number of investments they made in Biotech companies from France. We update this investor list every month.

Top 50 Biotech Startup Investors in France in January 2026

Investor	Biotech France investments
Bpifrance	62
GO CAPITAL	27
Kurma Partners	26
Sofinnova Partners	25
Seventure Partners	24
Karista	23
Elaia	19
Auriga Partners	17
Idinvest Partners	16
Omnes Capital	16
Angels Santé	13
Sofimac Investment Managers	12
AQUITI Gestion	11
AdBio partners	10
Cap Innov'Est	9
Inserm Transfert Initiative	8
Galia Gestion	8
IRDI SORIDEC Gestion	7
Pontifax	7
Meusinvest (Noshaq)	7
Crédit Agricole	7
WiSEED	7
Sham Innovation Santé	7
IRDI	7
CEA Investissement	6
UI Investissement	6
Octalfa	6
Paca Investissement	6
Crédit Mutuel Innovation	6
SOSV	6
Starquest Capital	6
M Capital Partners	6
Normandie Participations	6
Demeter	6
Emertec	5
Supernova Invest	5
XAnge	5
BNP Paribas Développement	5
Finovam Gestion	4
BNP Paribas	4
Truffle Capital	4
Rhone-Alpes Creation	4
Casdin Capital	4
Eurazeo	4
Bernard Majoie	4
Aurinvest	4
Pertinence Invest	4
Kima Ventures	4
Heartcore Capital	4
ACG Management	4

Find investors that fund startups like yours. Automatically.

Our algorithm will find investors that invest in your industry, stage, and geography.

Investor list

Bpifrance provides financial solutions for companies that are booting up the listing on the stock exchange and credit equity. It includes OSEO, CDC Entreprises, FSI, and FSI Regions to offer in your area of financial solutions at every stage of the life of your business.

Investment focus

Software, Information Technology, Health Care
Seed, Funding Round, Series A
France, United States, Switzerland

Portfolio highlights

AUSTRAL Dx — AUSTRAL Dx is developing a new imaging technique based on airborne ultrasounds in order to map the vibrations coming from the lungs. The company was founded in 2021 and is based in Paris.
IsentroniQ — Isentroniq solves the critical cryogenic power and space bottleneck in quantum computing. Our dense, near-heatless wiring solution unlocks 1000x more qubits.
Brevo — Brevo is a developer of a cloud-based digital marketing platform used to meet the demand of businesses to engage with customers. Its platform encompasses the entire chain, from the creation of a newsletter to analysis and reporting tools to targeting modules that enable businesses, eCommerce sellers, and agencies to build customer relationshipsthrough digital marketing campaigns, transactional messaging, and marketing automation.Unlike other marketing solutions built for enterprise-level budgets and expertise, Sendinblue tailors its all-in-one suite to suit the marketing needs of growing SMBs in tough markets.The company was founded in 2012 and is headquartered in Paris, France.

GO Capital is an independent management company and a major player in regional Seed and Venture Capital since 2003. With offices in Brittany, Pays de la Loire, Normandy, Centre-Val de Loire and the South of France, GO Capital contributes to the financing of responsible innovation in these regions. With a team of investors with complementarysectoral experience, we have a solid track-record in DeepTech. GO Capital has nearly 400 million euros under management, and mainly finances technology leaders in the digital and healthcare sectors and in the industry of the future.

Investment focus

Biotechnology, Software, Health Care
Funding Round, Seed, Series A
France, Canada, Israel

Portfolio highlights

AISPRID — AISPRID is a robotic company that manufactures autonomous robots for soft fruit picking.
BiOceanOr — BiOceanOr harnessed the power of Marine Biology and AI to deliver bio-guided services that optimize fish welfare and fish growth, while supporting aquaculture sustainability standards
Reelevant — Only 1 out of 10 people interact with marketing messages. Content is the bottleneck of personalization, not data. Personalization doesn't work because data are used to create targeted campaigns. Data must be used to create content because content creates interactions and drive conversion.Why: create content for people, not for campaigns(visual is the key to emotions) How: on-demand, when the user request, at the opening/reading/exposure (Pull content vs Push marketing) What: end-to-end widgets solutions like Live content, Individualization, Content Automation, Optimization, etc.Our visual content platform accelerates revenue, creates content based on any data (behavioral, contextual, etc.) created on the fly at the moment of exposure (on any channel (email, web, push notifications, in-app messages, etc.). We take advantage of existing data sources, nothing to create, we supercharge your marketing stack. Our data-driven Content Engine translates data from any source into on-demand visual content in milliseconds for each people.We believe in a new way of thinking about messages by shifting the paradigm of push marketing to transform any data into on-demand visual content. One unique content is created for each people on the fly at the moment people decide to read them (pull content), instead of when marketers decide to create them (push marketing).People are not data points, people don't buy products, they buy emotions. On-demand visual content is the new game!

Kurma Partners is a management company based in Paris, specializing in the financing of innovation in healthcare and biotechnology, from pre-creation to development capital. Kurma Partners, which manages the Kurma Biofund I, II funds and the Kurma Diagnostics fund, is one of the main players in the financing of therapeutic and medical innovationsin Europe, particularly through links with many institutes. research and prestigious hospitals.

Investment focus

Health Care, Biotechnology, Pharmaceutical
Series A, Seed, Series B
France, Switzerland, Spain

Portfolio highlights

DNA Script — DNA Script is a disruptive DNA synthesis company engineering biology to accelerate breakthroughs in life science and human health. Their revolutionary enzymatic technology powers the world's first benchtop DNA printer, SYNTAX, enabling labs to print their own synthetic oligos for greater workflow control and faster access to results.
Sunrise — Sunrise aims to bring simple answers to millions of people suffering from sleep disorders.We have developed a 3-gram sensor to diagnose sleep with gold standard quality. The technology offers a revolutionary new way to measure brain commands at night, with published clinical results never seen before. Studies demonstrate Sunrise is as accurate asin-lab sleep studies, at a fraction of the cost.Affecting one in three people, sleep disorders are extremely common. Sleep apnea is the most prevalent disease with almost 1 billion persons concerned. This condition leads to great body damage over time and yet remains undiagnosed in 80% of the cases.Patients, caregiver and insurers stand to benefit greatly from a solution to current highly cumbersome, expensive and time-consuming diagnostics systems.
Stilla Technologies — Stilla Technologies is taking digital PCR to a whole new level with a unique 6-color target detection capability

Sofinnova Partners is a leading European venture capital firm in life sciences, specializing in healthcare and sustainability. Based in Paris, London and Milan, the firm brings together a team of professionals from all over the world with strong scientific, medical and business expertise.

Investment focus

Biotechnology, Health Care, Medical
Series A, Series B, Series C
France, United States, United Kingdom

Portfolio highlights

DNA Script — DNA Script is a disruptive DNA synthesis company engineering biology to accelerate breakthroughs in life science and human health. Their revolutionary enzymatic technology powers the world's first benchtop DNA printer, SYNTAX, enabling labs to print their own synthetic oligos for greater workflow control and faster access to results.
AAVantgarde Bio — AAVantgarde Bio is developing gene therapies for inherited retinal disorders.
Excelsior Sciences — Rebuilding the World, From the Bottom Up

Seventure Partners is a French venture capital firm targeting in Tech/Digital and Life Sciences companies. It funds innovation and participates in the entrepreneurial adventure, alongside entrepreneurs and sharing their passion.Founded in 1997, Seventure Partners is one of the European leaders in venture capital, with € 1 billion undermanagement as of December 31, 2023. It is an active partner of innovative companies that, according to the management team, show strong growth potential and evolving in two fields of activity: Digital Technologies and Life Sciences. With more than 20 employees, including some 15 investors, Seventure Partners has a proven track record and in-depth expertise in technology, entrepreneurship, and various private equity operations.Seventure's goal is to identify and support the development of tomorrow's European leaders in order to accelerate their growth. To do this, the firm provides entrepreneurs with the expertise, networks, and know-how of its internal team of investors.The different funds/verticals on which Seventure Partners are focusing on today: - Life Sciences : Biotech, Healthcare, Nutrition - Tech/Digital : B2B SaaS, Fintech, Retailtech, Cybersecurity - Sports & Wellbeing - Blue Economy

Investment focus

Biotechnology, Health Care, Software
Series A, Funding Round, Series B
France, United States, Germany

Portfolio highlights

Sentryc — Protect your brand and your products from counterfeiters with Sentryc. We monitor over 120 marketplaces for you and remove potential counterfeits.
Flexvelop — Flexvelop combines financial technology with circular economy to add innovative values to the core function of equipment funding.Local vendors and online-shops integrate Flexvelop as a seamless embedded payment option. Business customers are now able to #flex new equipment per click right at the point of sale. Insurance is already covered, andour customers have now the weekly option, to buy- or return their equipment, easily. This enables a new world of worry-free and flexible business growth.We #flex business equipment from €300 up to €20.000 per item; e.g. coffee-machines, laptops, gym- or dental-equipment,... anything you need for your business.NEXT GENERATION PAYMENTS + Technological Innovation: fully automatic embedded payment option + Economical Innovation: optionality (rent/buy/return) + insurance included + Ecological Innovation: sustainability (contributing to a circular economy) = Enabling worry-free flexible business developmentForget renting. Forget leasing. Grow smart - flex it!
Hepster — hepster, die Onlineversicherung, flexibel, sicher und immer 100% digital.

Karista is an early-stage venture capital firm created in 2001 investing in Health, Digital, Tech, and NewSpace.

Investment focus

Software, Biotechnology, Health Care
Seed, Series A, Series B
France, United States, Finland

Portfolio highlights

CYSEC — Secure your sensitive data in the cloud and in the edge with ARCA Trusted OS and open the door to innovation with confidential computing.
Stootie — Stootie is a buyer-focused classifieds platform. It's mobile. It's local. And it's quick. Really quick!This is the tool you use to get that phone power outlet you forgot when you're working in a Starbucks. Or pretty much anything else. Anywhere. Anytime.The keywords of Stootie are : marketplace, P2P business, local,mobile, realtime, platform.Stootie is currently available on iOS and Android.
Exotrail — Exotrail is an end-to-end space mobility operator. Our mission is to enable small satellites to move in space, optimise their deployment, increase their service performance, and reduce space pollution.

Elaia is French venture capital firm focused on European digital and deep tech startups, from early stage to growth developpement. We back tech disruptors.

Investment focus

Software, Artificial Intelligence, Information Technology
Seed, Series A, Series B
France, United States, Spain

Portfolio highlights

Pili — PiLi biofabricates a sustainable alternative to create renewable inks to replace their toxic, non-biological, and non-recyclable versions.Pili was born from the reunion of a biologist, a designer, and a financial analyst at the biohacker space La Paillasse in Paris and with the creation of the first pen fed by bacteria. Its team is nowdedicated to providing the colors from micro-organisms to offer a sustainable alternative to fossil resources.
Djust — DJUST is the dedicated solution that helps companies launch their B2B eCommerce and eProcurement platforms faster
SeqOne Genomics — Healthcare is undergoing a revolution, known as genomic medicine, that uses the patient’s genomic information to optimise treatment. This trend is accelerating thanks to the arrival of New Generation Sequencing (NGS) techniques that have reduced the cost of decoding genomic material while increasing the amount useful data obtained. However, NGShas had only limited impact on mainstream healthcare due to the difficulties in analyzing more and richer genomic data. SeqOne’s mission is to provide tools that enable the healthcare industry to analyse NGS genomic data better and more cost-effectively to provide universal access to genomic medicine.

Since 1998, AURIGA PARTNERS, an independent Venture Capital firm, has been managing several early stage funds specializing in Information Technology and Life Sciences.

Investment focus

Biotechnology, Health Care, Medical
Series B, Series A, Funding Round
France, United States, Switzerland

Portfolio highlights

Amplitude — Amplitude is a leading manufacturer of femtosecond lasers. We are laying the foundations for advances in science, industry, and health care.
Pherecydes Pharma — Pherecydes Pharma operator of an innovative biotechnologies company created to develop personalized phage therapy to treat bacterial infections. The company develops bacteriophages against infections and launched multicenter European phage therapy trial to evaluate phage therapy on infected burn wounds, recognize bacterial target attached to itsouter membrane, inject genetic material and reproduce in the host to make new phages that get out and repeat the same cycle, enabling doctors to detect and treat people and their environment against a large range of biothreat agents, including multi-resistant, emergent or previously uncharacterized bacteria.
Median Technologies — We harness the power of Imaging Phenomics to contribute to the development of next generation treatments and care strategies for patients in need.

Idinvest Partners is a pan-European private equity manager focused on the low and middle-market segments. With over 6 billion euros under management, the company has developed several complementary areas of expertise, including equity investments in buyout deals focusing on both mid-size as well as young innovative European companies; primaryinvestments in European private equity funds focusing primarily on the middle market segment; secondary investments; mezzanine investments in Europe; and private equity consulting.Idinvest Partners’ recent success stories include Criteo, Clear2Pay, Meetic, Prosensa, Converteam, Kwik Fit, Lastminute.com, Dailymotion, Deezer, Talend, Synthesio, Menlook, Vestiaire Collective, Pretty Simple, Curse.com, Withings, Kantox, Secret Escapes, Happn, Peakon, Dayuse, Botify, Financefox, Azalead and many more.

Investment focus

Biotechnology, Health Care, Software
Series B, Series A, Funding Round
France, United States, Spain

Portfolio highlights

Corti — Corti offers a digital assistant, augmenting medics in improving patient outcomes and internal performance.
StarTower — StarTower is a resource company built specifically for fully decentralized physical infrastructure and shared interaction. Based on the exclusive RIP encryption technology, StarTower realizes the interactive sharing of multiple resources with zero loss on mobile devices, thereby providing efficient resource transmission for terminal facilities. Itprovides more efficient, secure and reliable solutions in the fields of Internet of Things, smart cities, industrial automation, healthcare, etc.
Stilla Technologies — Stilla Technologies is taking digital PCR to a whole new level with a unique 6-color target detection capability

Omnes VC is the Venture Capital arm of Omnes Capital, a leading private equity firm dedicated to energy transition and innovation with €4.8 billion in assets under management and a 20 year + experience in: venture capital, buyout & growth capital, private debt, renewable energy, co-investment, secondary funds of funds. Omnes Capital is fullyindependent.With 65 business sales including 14 IPOs carried out in 16 years, Omnes VC is one of the key players in France in financing innovative SMEs with expertise in both Technology and Healthcare sectors. Omnes VC has supported 120 companies and has invested more than €500M in businesses such as Scality, Novaled, BioVex, arGEN-X, Pixium, Blablacar.

Investment focus

Biotechnology, Software, Health Care
Series A, Funding Round, Series B
France, Germany, United States

Portfolio highlights

Caracol — Lead the future of manufacturing thanks to Caracol's 3D printing technologies. Discover our solutions for industrial, Large Format Additive Manufacturing.
Complix — Complix is a biopharmaceutical company focused on the discovery and development of Alphabodiesâ„¢, a novel class of biopharmaceuticals that offer significant advantages over existing protein based therapies. Alphabodiesâ„¢ bind with high affinity to a wide range of disease targets and are particularly suited to address certain targets that aredifficult to reach with antibodies or other types of protein scaffolds. Due to their unique stability and versatility Alphabodiesâ„¢ can be delivered via alternative non-injectable routes of administration, unlike most therapeutic proteins.
Amakem — Amakem is a kinase platform company focusing on ophthalmology and is developing new treatments for serious eye conditions. Amakem's product pipeline is based on its unique â€˜Localized Drug Action' platform which is designed to generate safe and effective novel kinase inhibitors that minimize systemic exposure with the aim of reducingside effects.

Angels Santé is the leading French Business Angel Network solely dedicated to Healthcare investments.

Investment focus

Health Care, Biotechnology, Medical Device
Seed, Funding Round, Angel
France, India, United States

Portfolio highlights

Abcely — Abcely is a biotech firm that is working on a novel anti-cancer medication.
Odimma — Empowering personalized immunotherapy to treat cancer
AUSTRAL Dx — AUSTRAL Dx is developing a new imaging technique based on airborne ultrasounds in order to map the vibrations coming from the lungs. The company was founded in 2021 and is based in Paris.

Acteur incontournable du capital risque de proximité, SOFIMAC PARTNERS accompagne depuis maintenant plus de 30 ans les PME régionales dans le financement de leur développement à moyen / long terme. Répondant à la problématique de sous capitalisation des PME françaises, SOFIMAC PARTNERS intervient en fonds propres aux côtés des chefsd’entreprises quelle que soit leur problématique : Création, Développement, Transmission. Gérant 200 M€ d’actifs au travers de 16 fonds (FCPR, FCPI, SCR, FIP,…), notre groupe réalise ses investissements sur une grande variété de secteurs, couvrant aussi bien les activités traditionnelles que technologiques (chimie verte, éolien, chaudronnerie aéronautique, e-commerce, édition de logiciel, médecine nucléaire etc…)

Investment focus

Biotechnology, Health Care, Manufacturing
Funding Round, Seed, Series A
France, Italy, Austria

Portfolio highlights

Ultrawatt — Ultrawatt is a mission-driven startup to improve urban architecture while making a beneficial social and environmental effect.
Mob-Energy — Mob-Energy is a privately held company specializing in the development of mobile and innovative charging solutions. It designs autonomous charging robots capable of moving energy where it is needed, optimizing the site's existing infrastructure. The company was founded in 2018 and is headquartered in Villeurbanne, Auvergne-Rhône-Alpes.
Snowleader — Votre boutique en ligne (qui sent bon le reblochon) spécialiste des sports d’hiver, outdoor et street.

Floated in 1998, thanks to the local authority "Conseil Régional d’Aquitaine" and the "Caisse des dépôts", our venture, growth and LBO funds (Aquitaine Amorçage, ACI, Aqui-Invest) now benefit from the support of public and private influential shareholders and sponsors.Up to now, AQUITI GESTION has invested in more than 200operations contributing to the creation and development of about 150 companies and thousands of jobs.Currently, ACI and Aqui-Invest manage a portfolio gathering 50 companies which revenues scale from 0 € (early stage) to 30 M€.

Investment focus

Biotechnology, Software, Manufacturing
Funding Round, Series A, Seed
France, United States

Portfolio highlights

Speeral — Speeral is a technological solution for user to access second-hand market and products.
Aquassay — Aquassay assists you with improving the industrial and environmental performance of all your water usage (supply, production, discharge).
Materrup — Materrup produces low-carbon earth concrete for construction and urban development. Materrup construction solutions meet the requirements of future RE2020 regulations and the urgent need to reduce the carbon footprint of the construction industry.

AdBio partners is a European Life Sciences Venture Capital firm dedicated to seeding healthcare’s step forward.We work with leading research institutions and well-established technology transfer offices, with a strong network of scientific and medical partners, exploring new territories to source breakthrough medical discoveries and driveinventive Life Sciences start-ups to success.We embrace European Life Sciences’ dynamic of innovation. Europe harbors a vibrant environment for medical and scientific investigation, with some of the most leading-edge academic and research centers. AdBio partners seizes the opportunity to highlight their undervalued research programs and assets and participate in structuring Europe’s biotechnology ecosystem.

Investment focus

Biotechnology, Health Care, Pharmaceutical
Seed, Series A, Funding Round
France, Spain, Belgium

Portfolio highlights

Cephagenix — Cephagenix focuses on identifying and developing new, effective migraine therapies.
Tenpoint Therapeutics — Tenpoint Therapeutics Ltd. is a global, clinical-stage biotech company developing groundbreaking treatments to rejuvenate vision in the aging eye.
Augustine Therapeutics — Augustine Therapeutics is developing selective, safe and efficacious HDAC6 inhibitors designed for treatment of neuromuscular, neurodegenerative and cardiometabolic diseases. Discover our pipeline poised for clinical impact.

Cap Innov’Est is a 36M€ tri-regional fund dedicated to investments in young innovative start-ups. Cap Innov’Est was launched in July 2014 and has already invested in 13 start-ups. Cap Innov’Est is supported by Fonds National d’Amorçage, the 3 Regions Alsace, Bourgogne and Franche-Comté, SAFIDI, caisses d’épargne d’Alsace etBourgogne/Franche-Comté, BNP Paribas et CIFC

Investment focus

Biotechnology, Pharmaceutical, Health Care
Seed, Series A, Funding Round
France, United States

Portfolio highlights

VistaCare — "Making Difficult Wounds Easy" : VistaCare is a Breakthrough and non-invasive Medical Device designed for treatment during the critical phases of the wound.
Opencell Software — Opencell was created in 2015 to leverage an open source telco billing project initiated in 2007 by David Meyer, their current CEO.Their mission is to provide the first agile monetization platform capable of filling the gap between costly and complex legacy billing solutions and the overly simplistic “one size fits all” SaaS solutions that coveronly the most basic requirements.Opencell is now the open source monetization and billing platform with over 40 successful implementations in multiple industries and countries.
Rhythm Diagnostic Systems — Many of our team have worked together on different projects and in different companies over the last 30-plus years. We are experienced technology, medical, health care and biotech professionals, with long, successful histories in Silicon Valley and elsewhere.

Inserm Transfert Initiative is a seed stage life science vehicle currently managing about â‚¬4.2M for the financing of new biotech companies. Inserm Transfert Initiative is the new investment vehicle of INSERM in France.

Investment focus

Biotechnology, Medical, Health Care
Series A, Series B, Seed
France, Switzerland, United States

Portfolio highlights

Eyevensys — Eyevensys is a address critical unmet needs in ophthalmology by providing a much better way of delivering ophthalmic drugs that overcomes the limitations of current options, such as intravitreal injections, surgery, intravitreal implants and biodegradable formulations. All of these current options have their drawbacks, given they are invasiveprocedures. Eyevensys’ goal is not only to improve short and long term therapeutic outcomes, but also to enhance compliance, improve ocular bioavailability and tolerability.They plan to build a high value product pipeline by enabling sustained production of therapeutic proteins in the eye that will deliver improved clinical outcomes while reducing the burden of frequent intravitreal or systemic injections and other invasive procedures.
VectivBio — Explore Ironwood Pharmaceuticals' commitment to GI health with innovative therapies, patient-focused research, and a vision to improve digestive disease treatment.
Aelis Farma — Aelis Farma is a pioneer in the development of signaling specific therapeutics that target GPCRs (and more specifically the CB1 receptor which is one of the most expressed GPCRs in the brain). GPCRs are the target of most therapeutic drugs. This family of receptors has the characteristics to activate several and often opposing signaling pathways.Unfortunately, most of the drugs acting on GPCRs either block or stimulate the entire signaling activity of the receptor resulting in unwanted and sometimes unacceptable side effects.

Galia Gestion is a private equity and venture capital firm. GALIA Gestion is a “management company” approved by the AMF, with majority shareholder Alliance Entreprendre.

Investment focus

Software, Manufacturing, Biotechnology
Funding Round, Series A, Seed
France, United States

Portfolio highlights

Wizaly — Wizaly's ambition is to help advertisers understand the impact of their online & offline marketing channels across all conversions, helping clients improve the ROI of their marketing budgets by up to 30%.The Wizaly platform applies its algorithmic attribution technology to provide a holistic and unbiased vision of campaigns performancestogether with actionable optimization recommendations.
Agenium — Agenium offers career perspectives in an international and tech environment. They offer this through the specific expertise of their business units. They offer solutions to the business and of the defense, industry, and space sectors.
Germitec SAS — Germitec is a world leader in UV-C high-level disinfection. Fast, safe, chemical-free, one-button UV-C high-level disinfection for ultrasound probes.

IRDI SORIDEC Gestion is a portfolio management company that supports startups, SMEs, and ETIs in the greater South-West of France with equity capital at all stages of development.

Investment focus

Software, Biotechnology, Manufacturing
Seed, Series A, Funding Round
France, Brazil, Singapore

Portfolio highlights

bYoRNA — bYoRNA is a French biotechnology company specializing in the cost-efficient, scalable bioproduction of high-quality therapeutic messenger RNA (mRNA) using engineered eukaryotic cells, particularly recombinant yeast. Their disruptive platform enables the production of long, humanized mRNA with lower immunogenicity and higher integrity compared totraditional in vitro enzymatic synthesis. This technology aims to mass produce mRNA for gene therapies, cancer vaccines, and infectious disease vaccines at a fraction of current costs, making mRNA therapeutics more accessible globally.
FEEDAE — Feedae uses AI-augmented dialog analysis to boost sales and customer service teams' performance.
Greenphage — Greenphage develops bacteriophage-based methods to address bacterial infections and contaminations in human, animal, and plant health. It uses bacteriophages to create alternatives to antibacterial treatments. The company conducts laboratory research on phage studies, molecular virology, and microbiology. It also works with research institutions tosupport its phage therapy efforts.

Pontifax is a healthcare-dedicated venture capital firm.The fund focuses on innovative bio-pharma opportunities.

Investment focus

Biotechnology, Health Care, Therapeutics
Series A, Series B, Series C
United States, Israel, France

Portfolio highlights

ADCendo — ADCendo ApS is a biotech company dedicated to developing new types of anti-cancer drugs. We focus on antibody-drug conjugates (ADCs) directed at novel targets, that have been found to be overexpressed by several cancer forms, that are all characterized by a significant unmet need for novel treatment.
Lutris Pharma — Improving anti-cancer therapy by reducing dose limiting side effects
Indapta Therapeutics — Indapta Therapeutics is a privately held biotechnology company developing an NK (natural killer) cell therapy platform for the treatment of blood and solid tumor cancers.

Noshaq offers financial services to help businesses develop.

Investment focus

Biotechnology, Health Care, Medical
Series A, Seed, Funding Round
Belgium, France, Germany

Portfolio highlights

TrustUp — TrustUp is the home contractors platform, connects homeowners with verified quality home improvement.
Veoware — More coverage, shorter revisit time. Increasing target collection frequency through modular next-gen actuator technology.
Le Fourgon — Le Fourgon provides contained drinks for home delivery. They offer milk, water, beer, wine, fruit juice, and sodas. They allow customers to have their drinks delivered free of charge during the day.

Credit Agricole is a banking corporation with focuses on corporate and investment banking, retail banking, and savings management. Crédit Agricole Group is a responsible, helpful bank serving 49 million customers, 7.4 million mutual shareholders, and 1.2 million shareholders. Crédit Agricole Group supports its customers in their plans and projectsin France and around the world, through its operations in all segments of the market including insurance, real estate, payment systems, asset management, leasing and factoring, consumer finance, and corporate and investment banking. Crédit Agricole also stands out for its dynamic, innovative corporate social responsibility policy serving the economy. This policy is based on a pragmatic approach that permeates throughout the entire Group and engages all its employees. Its recent inclusion in the Vigeo-NYSE Euronext extra-financial indices is recognition of this engagement.

Investment focus

Software, Manufacturing, Health Care
Funding Round, Seed, Debt Financing
France, United States, Italy

Portfolio highlights

Mowi — Home - Mowi Company Website
Eduservices — Eduservices network and pool a set of skills and resources for schools.
FlowPay — Open banking & payment solutions. FlowPay supporta la tua azienda nei flussi di incasso e pagamento con soluzioni innovative integrabili via API.

Wiseed is a crowdfunding platform that enables its users to invest in SMEs and enterprises. The platform offers investments for startups, real-estate firms, social innovation and renewable energy projects, and agriculture firms. It was founded in 2008 by Nicolas Seres and Thomas Merquiol and is based in Toulouse.

Investment focus

Software, Manufacturing, Biotechnology
Seed, Funding Round, Equity Crowdfunding
France

Portfolio highlights

Leasi — Leasi delivers a forward-thinking rental and resource management system for companies that engage in internal or external distribution of machinery. This is achieved through an ecosystem that emphasizes the excessive use of data and datasharing, with a focus on user experience. Our goal is to create a simpler, more streamlined, and more efficientworkday for industry players by leveraging the power of data and collaboration within the ecosystem to ultimately reduce emissions, increase efficiency and enhance profitability.
Aéronde — The Aéronde is an innovative electric airship with a toroidal shape (giant donut) of 15 meters in diameter, designed to offer a silent, energy-efficient flight with very low environmental impact. Inflated with approximately 400 m³ of helium, it can carry up to two people and equipment, with a payload of 200 kg .
Vaxinano — Vaxinano is a biotechnology company specialized in preclinical and pharmaceutical development of human and veterinary vaccines and drug delivery systems. Vaxinano was created in 2016, building on 25 years of research and clinical trials on vaccines and the patented technology of Pr Didier Betbeder.

Sham Innovation Sante is an innovation capital vehicle controlled and held by Sham, a mutual insurer specialized in risk management for health care, social welfare and community health organizations. Advised by Turenne Capital, Sham Innovation Sante's mission is to support innovative businesses in the health care sector through the growth anddevelopment phases of their life cycle.

Investment focus

Biotechnology, Medical Device, Medical
Series B, Series A, Funding Round
France

Portfolio highlights

Cairdac — Cairdac is a manufacturer of autonomous leadless pacing transcatheter system capable of powering the device with no battery-life limitation.
Therapixel — Therapixel is one of the leading French software companies specializing in artificial intelligence applied to medical imaging.
Germitec SAS — Germitec is a world leader in UV-C high-level disinfection. Fast, safe, chemical-free, one-button UV-C high-level disinfection for ultrasound probes.

IRDI Gestion aims to participate in the economic growth and job creation in their regions. For this, their teams create a real partnership with the companies they accompany, based on a relationship of trust and proximity.IRDI Gestion currently manages €150 million and has financial tools able to accompany the Southwest SMEs in the creationphase, development or transmission, with intervention tickets from equity € 100000 to € 5000000.Precursor of regional investment capital of the Southwest, with a presence of over 35 years, the IRDI Group consists of 3 SCR:- IRDI, created in 1981 to foster industrial growth companies based in the South West of France- MPcroissance, created in 1996 to assist small businesses in Midi-Pyrénées- IRDInov, created in 2012 under the leadership of the National Seed Fund (under the PIA) to fund the initiation of innovative companiesIn 2015, the management company IRDI Gestion, approved by the AMF, was formed to structure the group and bring new development projects.

Investment focus

Health Care, Biotechnology, Software
Funding Round, Series A, Series B
France

Portfolio highlights

REEV — REEV motorizes medical orthoses to help millions of people affected by gait disorders to walk, stand, sit and climb stairs with greater ease every day.
Starfish Bioscience — STARFISH Bioscience focuses on the creation and development of microbiological solutions for agriculture and vineyards. Our objective is to regenerate soils by restoring their microbiomes, increasing sustainability and productivity while minimizing environmental impact. We are dedicated to improving humanity's well-being and preserving theearth by inventing technologies that address the future difficulties of global agriculture.
Micropep Technologies — Micropep Technologies developes a non-GMO new generation of bioherbicides and biostimulants. Micropep, founded in 2016 in Toulouse, focuses on bioherbicides and biostimulants. The company uses plants’ natural molecules, called “micro-peptides”, to temporarily control expression of their genes and regulate plant growth but leaving their DNA intact.The company currently works on four development programs: germination, flowering, growth, and weed control.

CEA Investissement (SA), founded (as CEA Valorisation) in 1999, is a subsidiary of the CEA, a major player in technological research, development and innovation. The central mission of CEA Valorisation is to create economic value based on technological innovations. To fulfill this mission, they have developed two main activities: Investmentin seed capital in innovative start-ups / start-ups active in the technology areas of CEA. The Licensing of advising companies and public laboratories of innovation in creative strategy development and marketing rights to patent or know-how belonging to the CEA, other research organizations or innovative companies. In addition, CEA contributes to the financing of national investment in seed technology (activity "Fund of Funds"), this activity is developed through particular Emertec management and funds managed by this company (FCPR Emertec 2 Emertec Energy and Environment), the FCPR managed by ACE Security Management SA, an investment company in seed priming Minatec SAS. Their areas of technological expertise are mainly micro-and nanotechnology, health technologies, the New Technologies for Information and Communication (NTIC), advanced materials and technologies for energy.

Investment focus

Manufacturing, Biotechnology, Energy
Seed, Series A, Funding Round
France, Canada, United States

Portfolio highlights

HEXANA — HEXANA is an energy platform that combines flexible sodium-cooled fast neutron reactors with a thermal management system.
STELLARIA — Stellaria is a 200 MWe molten salt reactor with 20-year autonomy, delivering safe, sustainable nuclear power without refueling.
STELLARIA — Stellaria is reimagining sustainable rapid neutron nuclear energy.

Since 1967, the UI brand embodies a partnership with companies. Actor of the economy, UI has accompanied more than 120 SMEs over the last fifteen years, investing more than 550m € and giving substance to their development projects. Combining experience and corporate culture, UI has established itself as an involved and independent partner, able tocount on its shareholder leaders to favor, independently, the sustainable performance of the SMEs it accompanies.

Investment focus

Manufacturing, Software, Health Care
Private Equity, Series A, Seed
France, Spain, Canada

Portfolio highlights

DeepUll — DeepUll is a biotech company that focuses its activity on the development of a new diagnostic system for early-stage sepsis condition. DeepUll’s proposal is based on quickly identifying the pathogens and offering the antibiogram within a few hours on the one hand, and on using the data and learning about the patient’s immunological and functionalstatus on the other. The system allows doctors to predict the future appearance and evolution of sepsis within a short period of time and thus provide a suitable clinical response even before the symptoms arise.
Fizimed — Fizimed has made the choice to develop the EMY perineal probe with recognized health professionals. The probe is connected to a mobile app and associated with custom exercises. The probe captures the contractions of the perineal muscles in real time to allow the patient to do 5-minute exercises through fun games (jumping obstacles, jumping ...) sothat she remains motivated. The patient can follow her results as well as her progress in the application and unlock new universes according to the points obtained. Much of the effort of Fizimed's technical teams is focused on balancing a product, combining the quality and safety of a medical device, with a fun application to empower each woman. One goal: the simplicity of the product and the interface for home use.Beyond the product, the Fizimed team is committed to the fight against taboos related to urinary incontinence problems affecting one in ten women. She wants to "demystify" this topic so that every woman can find her adapted solution. An EMY community is being born on social networks in which the feminine hassles are put into images and discussed with humor, while talking about innovations that can simplify their daily lives.In summary, EMY by Fizimed is the connected and fun medical probe that allows women wishing to regain control of their perineum to do their home exercises. It was developed by a dynamic Alsatian start-up whose ambition is to remove taboos on a public health issue.
Fungu'it — A new generation of flavor ingredients for healthy, sustainable, and accessible food.

Octalfa is a France-based venture capital firm that offers a range of financial services.

Investment focus

Biotechnology, Health Care, Medical
Funding Round, Seed, Series A
France

Portfolio highlights

Mathym — Mathym - a nanotechnology company dedicated to the development, manufacturing and commercialization of nanomaterials and nanodispersions.
ORPHELIA Pharma — ORPHELIA Pharma is a French pharmaceutical company dedicated to the development and marketing of pediatric drugs for oncology and CNS diseases. ORPHELIA’s mission is to significantly improve essential medicines administered to children through the development of efficient, reliable and safe drugs with child-friendly formulations. We focus ondeveloping optimized formulations for the pediatric population of approved drugs as well as obtaining the approval for existing drugs in new pediatric orphan indications.
Sirius NeoSight — Sirius NeoSight is a biotech and pharmaceutical company that detects subclinical neo-cancers and provide treatment for it.

Paca Investissement is specializes in investing in startups and developmental stages. The fund invests in the Provence-Alpes-Côte d'Azur (PACA) region.

Investment focus

Software, Internet, Manufacturing
Seed, Funding Round, Series A
France

Portfolio highlights

GANGZ — Gangz is the first digital platform for talent recruitment: Models, hosts, extras and actors.
SailEazy — The SailEazy community offers all sailing enthusiasts the choice of freedom. A shared professional fleet, bases between the Atlantic and the Mediterranean ... discover a disruptive and innovative way of navigation. Throughout the year, 7 days / 7 and 24 hours a day, you can book and discover the high-performance sailboats of a professionalfleet, entirely managed by SailEazy. Subscriber, or punctual browser, autonomous or not, you have the choice. You freely determine your niche of reservation, without constraint time or duration, you choose your base of departure and your sailboat, according to your program (short exit, cruise, regatta, coastal, wide ...). Hourly pricing includes a 360 ° service keychain beyond the cost of the lease, including insurance, fuel, cleaning and equipment. Compulsive veiled, expert or contemplative, all members of the community have their way of navigating.
C4Diagnostics — C4Diagnostics developed a fast, reliable detection of microorganisms. Our Click-chemistry technology is at the core of our portfolio of diagnostic tests.

Crédit Mutuel Innovation is the evergreen venture capital entity of Crédit Mutuel Equity (€3.5 billion in capital). We invest €1-20M in life science, digital and deeptech companies from seed to growth stages.We help bold and ambitious entrepreneurs to develop their strong growth potential with our worldwide enterprise ecosystem (our 350+portfolio companies, our abroad subsidiaries, 150+ largest global corporates and the best-in-class experts). Because it takes more than 5 years to build a Unicorn, we invest our own equity and ensure durable partnerships with visionary leaders.Today, the 350 companies in which we have invested generate a cumulative annual turnover of €50bn and create more than 250,000 jobs.

Investment focus

Software, Health Care, Biotechnology
Funding Round, Series A, Series B
France, United States, Canada

Portfolio highlights

Obat — Obat is a saas solution provider that uses software for contractors and self-employed for invoicing.
Biomemory — Biomemory creates DNA Drives for large corporates and administrations.
Glopal — Glopal provides advanced international Google shopping solutions for ecommerce retailers and brands seeking to grow their businesses' globally.

SOSV is a global, deep tech venture capital firm that operates the HAX and IndieBio startup development programs focused on human and planetary health. SOSV invests $500,000 in startups at their inception as they onboard either HAX or IndieBio for a 4-6 month period designed to accelerate the raise of their next institutional round. SOSV joins thelater rounds of HAX and IndieBio graduates. HAX, based in a 35,000 sq ft facility in Newark, NJ, is equipped with machine tools, 3D printers, chemical, electrical and mechanical engineering labs, as well as on-staff engineering and design experts. SOSV's IndieBio has locations in NYC and San Francisco, both of which offer extensive services and facilities to founders including on-site BSL-2 labs, well equipped lab benches and hoods, and advanced lab equipment, such as chromatography equipment.

Investment focus

Biotechnology, Health Care, Software
Seed, Convertible Note, Pre-Seed
United States, India, United Kingdom

Portfolio highlights

MixRift — MIXRIFT - game developers specialized in Mixed Reality
unspun — From 3D scan to perfect fitting custom jeans. unspun makes each pair of jeans unique to your actual body and design. On a mission to reduce global carbon emissions by 1%. As seen in Fast Company's World Changing Ideas, Time's Best Inventions, and PopSci's Best of What's New. Welcome to the future of apparel.
Mesa Quantum — Unlock the potential of chip-scale quantum sensing for enhanced Position, Navigation, And Timing capabilities. Explore Mesa Quantum's practical solutions.

High Tech, Low Carbon: crafting tomorrow, today. We finance innovation to make tomorrow happen today. Starquest is a Montefiore Company.

Investment focus

Software, Manufacturing, Information Technology
Seed, Funding Round, Series A
France, Singapore, The Netherlands

Portfolio highlights

auum — auum is a glass cleaning machine that optimizes the cleaning process and reduces its water consumption. It is also an economical cleaning technology designed to promote reusable containers at work. They offer service, maintenance, and replacement services.
Leakmited — At leakmited they reduce Non Revenue Water by finding leaks and by predicting risky pipes.They collect the client's Geographical Information System providing locations of the infrastructure and the history of breakdowns and leakages.
Hydroclimat — Hydroclimat is a French DeepTech company using AI and climate data to help industries and authorities manage climate risks.

M Capital is an independent investment company with +€500m AuM. A unique hub where entrepreneurs can have an equity finance and quasi-equity as well as a permanent support to accelerate their growth. In 2020, M Capital has funded over 200 French companies.

Investment focus

Health Care, Software, Food and Beverage
Funding Round, Seed, Series A
France, United States, Canada

Portfolio highlights

Fasst — Fasst is involved in the creation, distribution, consulting, and connection of unique digital insurance solutions for brokers and insurers.
Hakbah — Hakbah is a Fintech startup focusing on an alternative financial saving. Hakbah is modernizing financial saving via its intelligent platform by offering a comprehensive one-stop-shop solution for Savings Groups to initiate, manage, join, and pay directly within the mobile app.
Demether — Demether is a DeFi protocol that works to enable zero-cost access to TVL for blockchains.

Normandie Participations is a venture capital fund that co-invests in companies based in Normandy. It invests through equity and quasi-equity in small and medium-sized enterprises. The firm was founded in 2016 and is based in Colombelles, France.

Investment focus

Biotechnology, Software, Health Care
Funding Round, Seed, Series A
France

Portfolio highlights

RMAN Sync — RMAN Sync is the collaborative SRM by AI and deep learning that develops synergies between purchasing, supply chain, and trade.
Loop Dee Science — Loop Dee Science is a DNA startup that makes molecular biology diagnostics. They develop and manufacture field genetic analysis kits for the detection of pathogen DNA and RNA. Their automatic field analysis device is a multi-spectral analysis device that provides local output and can also be connected via USB or Bluetooth.
Good Motors agency — Good Motors agency offers self-service motorcycle rentals near train stations and airports in France's most beautiful regions.

Demeter is a major player in venture capital and private equity for the energy and ecological transition. They invest from 500 K€ to 30 M€ to support companies at all stages of their development: innovative startups, high growth SMEs and infrastructure projects.

Investment focus

Manufacturing, Software, Renewable Energy
Funding Round, Seed, Series A
France, Germany, Slovenia

Portfolio highlights

Lixo — Lixo develops software solutions to improve the performance of recycling companies, from waste collection to sorting and recyling
Phagos — Phagos uses AI and phages to create personalized bacterial treatments in 2 months. Our sustainable antibiotic alternative targets specific bacteria without resistance, serving chicken, cattle, swine, and shrimp farms worldwide.
SWEETCH Energy — SWEETCH Energy is developing a breakthrough technology in the field of salinity gradient power harvesting.

EMERTEC’s experienced investment team has developed proven track record and has been able to develop close ties with major industrial players, many of them also being investors in their funds.These close ties are extremely valuable as to understand medium and long-term requirements of major order placers and high-level commercial opportunities.This brings visibility and confidence for entrepreneurs as well as for its investors.Their objective is to create value by turning ground-breaking technological innovations into commercial and financial successful companies.

Investment focus

Biotechnology, Energy, Software
Series A, Funding Round, Series B
France, Canada, United States

Portfolio highlights

Ynsect — We are the world leader in insect ingredient production for animals, people, and plants. Our goal? To make the way we eat more nutritious and sustainable.
eLichens — eLichens is a sensor tech company that takes sensor technology to the next level. Its mission is to empower people, companies, and government agencies to improve air quality, both indoor and outdoor.
Osmia — Osmia SAS provides crop pollination services to improve yield and quality of agricultural production. Osmia intervenes in the context of specific problems on entomophilous or anemophilic pollination. Methodological approach and experience enables the company to find relevant solutions. It offers pollination studies and services for pre-base, baseor multiplication seeds. It also offers simple and efficient pollination services for arboriculture and optimize the yields and the quality of the productions of fruit trees.Osmia SAS was founded on 2014 and is headquartered in France.

we believe that top scientists and ambitious entrepreneurs can build a world where cutting-edge technologies shape the next generation of industry leaders.

Investment focus

Health Care, Manufacturing, Medical Device
Series A, Funding Round, Series B
France, Israel, Denmark

Portfolio highlights

Traxens — TRAXENS delivers the world's most exhaustive, precise and timely information on containers and container transporters allowing all stakeholders in multi-modal transport to improve costs, optimize investment, and offer premium services.To attain this performance TRAXENS led a 3-year R&D program to develop specific technology required toproduce cost effective, durable and autonomous devices for a wide range of container data capture and real-time transmission of this data from anywhere on the globe.
CrowdSec — CrowdSec is an open-source and collaborative security stack leveraging the crowd power. Analyze behaviors, respond to attacks & share signals across the community. Join the community and le's make the Internet safer, together.
Unseenlabs — Unseenlabs designs and develops a spectrum surveillance payload which is designed to detect and track non-cooperative vessels wherever they happen to be in the world.

XAnge is a Franco-German team of venture capital investors that manages €450 million and invests in digital, deeptech, and impact startups.It is the innovation brand of the Siparex group, a major player in French private equity. XAnge is a key European investor in early-stage startups and is looking for game-changing startups and entrepreneurswho rock the code[s].The Paris, Ile-de-France-located company was founded in 2004.

Investment focus

Software, Information Technology, SaaS
Series A, Seed, Series B
France, Germany, Belgium

Portfolio highlights

Animaj — Explore the future of storytelling where AI meets creativity at Animaj Lab. Join us on a journey to revolutionize kids' entertainment, crafting captivating content that keeps the digital-first generation engaged and inspired.
Ensweet — Ensweet is a telemedicine platform intended to offer telerehabilitation services to patients. They offer equipment so that everyone can exercise whenever possible, enabling patients to have accessible rehabilitation.
Diagnoly — Diagnoly provides AI-powered ultrasound assistant that enhances fetal screenings with real-time analysis, instant insights, and zero workflow disruption.

BNP Paribas Développement is the investment arm of BNP Paribas that specializes in SME development. It specializes in second stage, mezzanine, bridge, acquisition, leveraged buyouts, management buyouts, recapitalization, special situations, and privatizations transactions.The firm considers investments in manufacturing, service industries,medicine, electronics, energy, chemistry, new materials, industrial automations, industrial goods and services, transportation, consumer goods, commerce and distribution, buildings and public works, wholesale retail, biotechnology, telecommunications, and information technology sectors.BNP Paribas Développement was established in 1988 and is based in Paris, France.

Investment focus

Software, Information Technology, Health Care
Funding Round, Series A, Seed
France, Germany, The Netherlands

Portfolio highlights

DESKi — HeartFocus is an AI-powered heart exam software for ultrasound and can be used with any hand-held probe, cart or ultrasound system. The product is available as an APP or SDK and is appropriate for clinics, health systems and learning institutions
Poppins — Mila merges music, technology, and neuroscience to reshape therapy into a musical experience. We create musical games for children based on neurologic music therapy methods. These games are designed to address learning dissabilities like dyslexia, providing a digital treatment at home and helping identify these conditions. Behind these games, weleverage data science and new technologies to interpret learning, language, and motor performance into a cognitive score. Our goal is to improve the process for patients receiving treatment and to reaching the vast undiagnosed majority.
Eduservices — Eduservices network and pool a set of skills and resources for schools.

Finovam Gestion is an investment company approved by the AMF which takes minority stakes in innovative SMEs with high growth potential.The company, which manages €50M, invests in companies that have developed innovative offers in the following target sectors: Information and Communication Technology, Health and Biotechnologies, Agro-resources andEcotechnologies.Finovam Gestion has built solid relationships with the ecosystem of entrepreneurship (Industrials, Poles of Competitiveness, Incubators, Accelerators, Universities, and Research Centers) in all the sectors that we target in order to be able to source and do emerge the best companies.Among our investors (LPs), we can count BPI France, manufacturers (ADEO, LESAFFRE, TEREOS), banks (BNP Paribas, Caisse d´Epargne, Crédit Agricole) and the Haut de France and Grand-Est regions.

Investment focus

Information Technology, Software, Medical Device
Seed, Funding Round, Series A
France, United States

Portfolio highlights

Nijta — You have tons of speech data but handling it is a compliance minefield. Leverage the power of Nijta's AI-based voice anonymisation to use your data at scale without compromising privacy and confidentiality.
Selvitys — Selvitys is a fully automated method for designing, delivering, and analyzing online surveys.
BiblioOnDemand — BiblioOnDemand is a provider of digital library services that offer a diverse selection of ebooks and audiobooks.

BNP Paribas provides banking, financing, investment, savings, and protection solutions. The Group's three operational divisions are mobilized to support each type of clientele in their growth and development projects including corporate and institutional banking, commercial, personal banking, investment and protection services. The companyprovide financing and investment services to retail customers, associations, businesses, and corporations.

Investment focus

Financial Services, Information Technology, Software
Debt Financing, Funding Round, Post-IPO Debt
France, United Kingdom, United States

Portfolio highlights

Odata Brasil — Odata Brasil S.A. operates a network of data centers. The Company provides colocation services, as well as infrastructure solutions for electronic equipment.
Akaysha Energy — Discover innovative and sustainable renewable energy solutions with Akaysha Energy. Powering Australia's future with clean, reliable energy.
Fosun Tourism Group (FOLIDAY) — Fosun Tourism Group provides a one-price, all-inclusive leisure and vacation experience. Their tourist destinations include one-stop entertainment and comprehensive tourism and vacation destinations operated by a company that provides resort operations, tourism destination development, and other related services.

More than an investor, an ecosystem, For 20 years, Truffle Capital has been financing innovation, developing and supporting pioneering technologies in the fields of healthcare and finance

Investment focus

Biotechnology, Financial Services, Software
Funding Round, Series A, Series B
France, United States, Belgium

Portfolio highlights

DgPays — Dgpays are into fintech which provides end-to-end payment system for Banks, E-Money Institutions, Telecom and Transportation Operators.
Levenue — Levenue is a platform that helps recurring revenue businesses to get funded without dilution of shares
Wyden — AlgoTrader is the global institutional leader in algorithmic trading and execution infrastructure for both digital and traditional assets. With its advanced software solutions, AlgoTrader gives banks, hedge funds, brokers, crypto funds and other financial institutions an end-to-end platform for best execution and event-driven alpha generation. Thecompany's offering includes WIRESWARM, a digital asset trading and connectivity platform for banks and brokers, AlgoTrader QUANT, an end-to-end quantitative trading solution with automated trade signal generation and order execution, and AlgoTrader OEMS, a state-of-the-art Order and Execution Management System for systematic and discretionary buy-side institutions with managed connectivity to over 400 liquidity venues. AlgoTrader’s interdisciplinary team of quantitative strategy developers, senior software engineers and financial and crypto experts is shaping institutional trading. Founded in Switzerland and based in Zurich, New York and Singapore, AlgoTrader operates globally.

Rhone-Alpes Creation is a venture capital firm that focuses on early-stage investments in software and biotechnology.

Investment focus

Environmental Engineering, Software, Manufacturing
Seed, Funding Round, Series A
France

Portfolio highlights

Quotelo — Quotelo creates an automatization system for hoteliers to regain commercial independence in the hospitality industry and digitizes group-event-seminar reservations. The company's platform centralizes all requests and reservations for groups, events, and seminars for any type of establishment by adding a graphical chatbot to each hotel'swebsite and collecting MICE and group requests from customers automatically generating commercial proposals and reserving the rooms, restaurants, activities, and nights requested, allowing hotels to book seminars, meetings, or even events online and improve productivity, responsiveness, image, and predictability.
CentrExpert — CentrExpert provides global safety solutions for training, material audit transformation of standard industrial equipment to make it usable in areas with certification and after-sales service. The company is committed to converting machines and equipment, enabling it to be used in explosive atmospheres, more commonly known as ATEX zones.CentrExpert was founded on 2011 and is headquartered in Chasse-sur-rhône, France.
APIX Analytics — APIX Analytics is a nano-silicon based chemical analysis for industrial, environmental, and security applications. The company focuses on the development of miniaturized multigas analyzers systems based on integration on silicon of analytical chains such as sampling, injection of gases, separation of complex gas mixtures to improve specificity anddetection, identification, and quantification of each mixture compound.APIX Analytics was founded on 2014 and is headquartered in Grenoble, France.

Casdin Capital is a fundamental research investment firm focused on the life sciences and healthcare industry. It manages a long-short equity fund and makes investments in early-stage to late-stage private investments. Casdin was launched in 2012 by founder and CIO Eli Casdin and as of October 2020 has approximately $2.2 billion in assets undermanagement.

Investment focus

Biotechnology, Health Care, Therapeutics
Series B, Series A, Series C
United States, France, China

Portfolio highlights

Leyden Labs — Leyden Labs helps people live freely by developing products that protect from known and new respiratory viruses.
Octave — Octave Bioscience is an early-stage molecular diagnostics company focused on neurodegenerative diseases and conditions. The company was co-founded by Melinda Thomas and William Hagstrom in 2013. Octave Bioscience is headquartered in Menlo Park, California, United States.
Auron Therapeutics — A differentiated approach to cure cancer.

Eurazeo is a private equity and venture capital firm that invests in SMEs and manages a diversified portfolio of assets.With its expertise in private equity, real estate, and private debt, the group supports companies of all sizes in their development commitment through the commitment of its 235 professionals. It provides companies with thenecessary investments needed to realize their growth potential.The firm was founded in 1969 and is based in Paris, Ile-de-France, France.

Investment focus

Software, Information Technology, Health Care
Funding Round, Series B, Seed
France, United States, United Kingdom

Portfolio highlights

PPRO — From PSPs to tech companies, our partners depend on us to build their digital payments offering so they can free up their time and resources.
Dexory — Discover charming holiday accommodation in Whitby with i-stay. Modern comfort, prime locations, and easy booking for your perfect coastal getaway.
Neo4j — Connect data as it's stored with Neo4j. Perform powerful, complex queries at scale and speed with our graph data platform.

Bernard Majoie - President @ Fournier-Majoie

Investment focus

Biotechnology, Medical, Health Care
Seed, Pre-Seed, Series A
France, Belgium

Portfolio highlights

reMYND — Driving the development of disease-modifying treatments
AgenT — AgenT develops the first blood diagnosis to detect Alzheimer's years before the onset of the irreversible symptoms.
PEP-Therapy — PEP-Therapy is a French biotechnology company developing first-in-class peptides as targeted therapies in oncology

Aurinvest is a venture capital fund it is managed and primarily funded by more than fifty entrepreneurs and business leaders, alongside with institutional investors. The company's goal is to invest in high growth companies or ventures which are on the edge of an exciting journey. It accompanies the founders in successfully carrying out theirplan. With this purpose, each holding is coached by two experienced professionals who stay in close contact with companies' management and who interface with Aurinvest's network.

Investment focus

Software, Biotechnology, E-Commerce
Funding Round, Series B, Series A
France, United States, Belgium

Portfolio highlights

Famoco — Empower your business with secure mobile solutions, from Android professional devices to remote and real-time monitoring of fleets.
PathoQuest — PathoQuest provides biosafety assays based on next-generation sequencing (NGS) for biologics quality testing. GMP biotesting for biopharmaceuticals. Learn more.
Evercontact — Let Evercontact connect the dots in your life by turning your emails into an always-updated address book!

Pertinence Invest is an investment Firm that works with tech start ups.

Investment focus

Biotechnology, Medical, CRM
Seed
France

Portfolio highlights

BIOMAE — BIOMAE provides biomonitoring tools to measure contamination and toxicity of aquatic environments. The company presents tools for measuring and monitoring the quality of aquatic environments from markers of effects on a pollutant invertebrate transplanted directly into the environment. The biomonitoring tools come from years of research, making itpossible to analyze the bioavailability of the contaminants and the degree of toxicity, directly in the medium. The company operates a methodological breakthrough to identify the issue of diagnosis for environmental quality monitoring.BIOMAE was founded on 2014 and is based in Gaillard, France.
Skinjay — Skinjay presents you with an opportunity to combine a priceless moment of well-being with a daily ritual: SHOWERING.Thanks to a concept that offers an innovative and particularly effective method for diffusing essential oils into shower water, Skinjay helps you benefit from the positive effects of Aromatherapy and Aromachology directly on yourbody and through inhalation, all the while you enjoy an intense moment of well-being in the shower.Adopt Skinjay, install the Module in your shower very easily, and choose the essential oil shower capsules depending on your wishes and needs on the day.The Aromachology capsules from the ODYSSEY collection will stimulate your senses and take you on an intense emotional journey to the heart of your memories, while the Aromatherapy capsules from the MISSION collection.Will ease the minor ailments of your daily life thanks to the recognised beneficial qualities of essential oils.
Mablink Bioscience — Mablink Bioscience is a biotechnology company specialized in the development of a new class of cancer drugs, called Antibody Drug Conjugate (ADC).

Kima Ventures promotes the growth of startups, supporting them in the fastest and most effective ways.

Investment focus

Software, SaaS, Information Technology
Seed, Pre-Seed, Series A
France, United States, United Kingdom

Portfolio highlights

Retab — Cube AI boosts back-office logistics efficiency, allowing teams to handle more loads and focus on human relationships.
AUSTRAL Dx — AUSTRAL Dx is developing a new imaging technique based on airborne ultrasounds in order to map the vibrations coming from the lungs. The company was founded in 2021 and is based in Paris.
Aircap — Aircap revolutionizes investment with a banking platform dedicated to investors.

Heartcore Capital invests in companies re-enchanting the world through technology.

Investment focus

Software, FinTech, Artificial Intelligence
Seed, Series A, Series B
Denmark, United States, Germany

Portfolio highlights

Voyfai — Voyfai provides a platform to manage shipments, procurement, back-office tasks, and logistics services for freight forwarders.
IsentroniQ — Isentroniq solves the critical cryogenic power and space bottleneck in quantum computing. Our dense, near-heatless wiring solution unlocks 1000x more qubits.
IXI — Discover adaptive glasses with autofocus lenses that adjust to your viewing needs, providing seamless clarity at any distance.

Smalt Capital anciennement ACG Management, est un acteur majeur depuis plus de 20 ans

Investment focus

Software, Health Care, Biotechnology
Funding Round, Seed, Series A
France, Madagascar

Portfolio highlights

Kamp'n — Partenaire de croissance Facebook Ads & Google Ads
Little Cigogne — Little Cigogne is reinvents the shopping experience for children.
My Coach Football — My Coach Football allows you to manage and organize the daily operations of your football team, day after day, season after season. Designed to answer amateur and professional coaches’ needs, the platform centralizes all of your squad’s information and allows to gain time and efficiency. In a single click, you can manage players and their personalinformation, the preparation of training and games, but also individual and collective statistics. Season after season, you keep all those data and hence enjoy an optimum tracking of your team’s progression.

Investors by industry

Community

Artificial intelligence